Exact Sciences (EXAS) Stock Trades Up, Here Is Why - ca.finance.yahoo.com
2 hours ago • Google News
EXACT Sciences Corporation (EXAS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 9.09B
P/E Ratio
0.00
Revenue (TTM)
$ 2.94B
Volume
0
52W High
$ 72.83
52W Low
$ 38.81
Dividend Yield
0.00%
Beta
0.93
Technicals
50-Day MA
48.9676
200-Day MA
51.4163
52 Week High
72.83
52 Week Low
38.8118
About EXAS
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect.
Employees
6900
Headquarters
Madison, WI
CEO
Mr. Kevin T. Conroy J.D.